Jessica Burgers, MD
Surgical Oncology · Fort Lauderdale, FLNPI 1407113475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 22 payments — averaging $136.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$483
- AbbVie$479
- Vector Surgical, LLC$390
- Endologix LLC$358
- Stryker$283
- Silk Road Medical, Inc.$216
- plus $792 from 8 others
What the payments were for
- Food & beverage$3,001100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 1 | $483 |
| AbbVie(2 entities) | 4 | $479 |
| Vector Surgical, LLC | 2 | $390 |
| Endologix LLC | 3 | $358 |
| Stryker | 2 | $283 |
| Silk Road Medical, Inc. | 1 | $216 |
| Kerecis Limited | 1 | $147 |
| CSL Behring | 1 | $123 |
| Hologic Sales And Service, LLC | 2 | $120 |
| Axogen | 1 | $104 |
| Surmodics, Inc. | 1 | $95 |
| Myriad Genetic Laboratories, Inc. | 1 | $78 |
| Medtronic | 1 | $70 |
| Endomagnetics Ltd | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$589
- MOLLI$492
- EXPAREL$483
- ALLODERM$334
- ENROUTE Transcarotid Stent$216
- ENROUTE Transcarotid Neuroprotection System$216
- Alto Abdominal Stent Graft System$209
- MarginMarker$200
- FlowTriever$160
- AFX$149
- Ovation$149
- Kerecis GraftGuide$147
- NATRELLE$145
- Kcentra$123
- EIKON$123
- AVANCE NERVE GRAFT$104
How this compares
$3,001 in reported general payments places this provider in the 60th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 13 | $157 |
| Tramadol Hcl | 25 | $31 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Fort Lauderdale
- Omar RashidFort Lauderdale$9K
- Neha GoelMiami$200K
- Jonathan ZagerTampa$191K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Pamela HodulTampa$94K
- Mehran HabibiMiami$73K
- Paul BloomstonFort Myers$68K
- Kristin RojasMiami$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.